Electro-medical safety tester meets new IEC 62353 standard

Rigel Medical, part of the Seaward Group, has launched a new biomedical electrical safety analyser.

Photo: Electro-medical safety tester meets new IEC 62353 standard

The Rigel 288 which meets the IEC 60601, and the forthcoming IEC 62353 in service test standard for electromedical equipment. ‘The ergonomically designed, hand-held safety tester combines innovative lightweight design and advanced test technology with a range of special features including battery power, blue tooth connection for data transfer and a menu driven easy to operate user interface.’

The analyser provides automatic, semi-automatic or fully manual electrical safety testing of all electromedical equipment. Importantly, preset or customised test programmes can also be selected to enable users to comply with individual, local or international standards outside the scope of IEC 62353 and IEC 60601 to provide fast and efficient testing of medical equipment with up to 10 individual patient connections or applied parts, Rigel adds. ‘The instrument’s internal memory can be used to store details of test results for transfer to a PC database, alongside user defined inspections and checks on such equipment as SpO2, NIBP, ECG and other electromedical equipment.’

This, with the Rigel 277 and Rigel 266 and Rigel 300 series (which includes a range of testers to verify the functionality of NIBP testers, pulse oximetry analysers, ventilators and defibrillators) and the company’s other test equipment, are on show at MEDICA.
Hall 11. Stand G48

14.11.2006

More on the subject:

Related articles

Photo

News • HPV oncoprotein quantification

Urine test improves cervical cancer early detection

A new test shows promise in making cervical cancer screening more accessible and less invasive by detecting oncoproteins of the human papillomavirus (HPV) in urine samples.

Photo

News • Circulating tumor extracellular vesicles

Metastatic prostate cancer: better monitoring with new liquid biopsy method

A new study shows that extracellular vesicles shed by prostate cancer cells contain tumor-derived material that can be used as biomarkers of therapy response and resistance in metastatic disease.

Photo

News • Combined ESR and CBC/DIFF

Horiba launches new compact hematology analyzers

Analytical and measurement technology specialist Horiba has expanded its compact hematology instrument range with the launch of new models with Erythrocyte Sedimentation Rate (ESR) on board.

Related products

Subscribe to Newsletter